Navigation Links
Lower in Biological Technology

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

... period in 2008. This decrease is primarily due to lower royalty income from our relationship with ... period in 2008. This decrease is primarily due to lower royalty income from our relationship with ... expenses due to reduction in personnel and lower advertising and tradeshow expenses. In addition, ...

GenVec Reports Second Quarter 2009 Financial Results

... compared to the comparable prior year periods. lower revenues under both the FMD and malaria programs ... to the prior year. Also contributing to the lower revenue under the malaria program for the ... The decrease in both periods is primarily due to lower personnel costs, reduced patient, site, lab, data ...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

... a decrease of approximately 2 percent, reflecting lower off-label physician prescriptions of Actimmune ... decrease of approximately 17 percent, reflecting lower off-label sales of Actimmune for the treatment of ... strategy are less frequent administration and a lower dose or pill burden for ITMN-191, which may ...

Telik Announces Second Quarter 2009 Financial Results

... Operating expenses were approximately 43% lower in the second quarter of 2009 compared with the same period in 2008, primarily due to lower headcount as a result of our restructuring in ... research, clinical trial and related expenses and lower stock compensation expense. For the six ...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... to the second quarter of 2008 is due primarily to lower sales of medical device components to other third ... The decrease in royalty revenues was a result of lower sales of TAXUS stents by BSC, driven primarily by ... thinner stent struts, increased flexibility and a lower stent profile while improving radial strength, ...

PDI Reports 2009 Second Quarter Financial Results

... ago period. These declines are primarily due to lower revenue. The overall increase in second quarter ... 2009 operating expenses were $1.0 million, or 9%, lower than 2008. This decline is primarily attributable ... in 2009 compared to 2008 due to a combination of lower available cash and cash equivalents and the ...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... 53%, or $131 million to $116 million as the lower ADDERALL XR revenues in Q2 2009 were partially ... offset by higher revenues on other products and lower operating expenses on a Non GAAP basis. On ... 53% to $115.5 million (2008: $246.5 million). The lower product sales of ADDERALL XR in Q2 2009 were ...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

... enhancer could potentially allow the usage of lower quantities of Reb-A, maintaining the desired ... Also contributing to these decreases were lower patent and trademark expenses primarily ... Company's intellectual property portfolio, and lower non-cash stock-based compensation expenses. ...

Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009

... of fiscal 2009. The Company attributes the lower fourth quarter sales growth rate to continued ... year ended June 30, 2009 were primarily caused by lower gross margins in Europe resulting from ... higher margin Biotechnology Division sales to lower margin Hematology Division and R&D Europe ...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

... largest market, and the U.K. served to offset lower revenue in Germany. In France, revenues ... to increased sales and gross profit, as well as lower R&D expense, partially offset by higher ... made in December 2008 and March 2009, as well as lower overall interest rates. Other income, net, for ...

Sigma-Aldrich (Nasdaq:SIAL) Reports Q2 2009 Diluted EPS of $0.68; YTD Diluted EPS up 1.5% to $1.36. Full Year 2009 Guidance Reaffirmed, With 2009 Diluted EPS Expected to Exceed 2008's $2.65.

... benefits from global supply chain activities, lower S,G&A costs and strategic pricing actions to ... continuation of the cost improvement efforts, lower interest rates, and exchange rates remaining at ... to the timing of international tax payments, a lower level of net income and a small increase in ...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

... Cancer, Cerebrovascular Diseases, Chronic lower Respiratory Diseases, and Accidents ... Cancer, Cerebrovascular diseases, Chronic lower respiratory diseases, Accidents ... Cancer, Cerebrovascular Diseases, Chronic lower Respiratory Diseases, and Accidents ...

Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update

... in part, higher purchase costs resulting from a lower Canadian dollar versus the U.S. dollar and ... the aforementioned increases in expenditures are lower wages and benefits from the foregoing of accrued ... by management during the current fiscal year and lower wages and benefits due to a one-time charge ...

Lumbar Matrix(TM) Scan From SpineMatrix(R) Revolutionizes the Diagnosis of Low Back Pain

... diagnostic methods used most frequently to detect lower back pain - such as X-rays, magnetic resonance ... including surgery, may follow misdiagnosed lower back pain, further elevating healthcare spending. ... which helps physicians to differentially diagnose lower back pain by identifying disc, facet and muscle ...

OncoGenex Pharmaceuticals Announces OGX-011 Treatment Provides Survival Benefit in Randomized Phase 2 Trial in Advanced Metastatic Prostate Cancer

... with OGX-011 had a rate of death 51% lower than patients treated with docetaxel alone ... exploratory analyses found that the lower rate of death was associated with the effect of ... (i.e. OGX-011 treatment resulted in a lower rate of death when compared to the ...

Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

... Cardiac toxicity may also occur at lower cumulative doses (400 mg/m2) in patients with ... than or equal to 5% decrease below institutional lower limit of normal) ... agents (ESAs) to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 ...

Insmed Announces First Quarter 2009 Financial Results

... most recent first quarter of $23,000 was $256,000 lower than the corresponding quarter of 2008 due to a combination of the lower interest rate environment and a lower average cash balance. Interest expense of ...

SENOMYX ANNOUNCES FIRST QUARTER 2009 FINANCIAL RESULTS

... in 2008. The decrease was primarily due to lower costs related to scientific supplies and lower personnel expenses. General and ... the research funding period by one year and lower the funding that Senomyx will receive to reflect ...

Savient Pharmaceuticals Reports First Quarter 2009 Financial Results

... ended March 31, 2008. The decrease was due to lower gross product sales of Oxandrin(R), our product ... impact of generic competition partially offset by lower provisions for product returns year over year. ... Partially offsetting these higher expenses were lower validation and technology transfer costs relating ...

Solutia Reports First Quarter 2009 Results

... in all world markets, partially offset by lower raw material and SG&A costs, and higher ... in the same period in 2008, primarily due to lower window films revenue, partially offset by reduced ... in the prior year period, primarily due to lower volumes partially offset by improved selling ...

Cambrex Reports First Quarter 2009 Results

... quarter 2009 sales of $60.0 million were 2.8% lower than the first quarter 2008. Sales were ... custom development revenues, partially offset by lower sales of generic APIs. First quarter 2009 ... favorably impacting gross margin by 6.0%. lower production levels and the ...

Shire begins the year with a strong performance

... basis) with higher revenues supported by lower costs driving improved margins. The lower costs are a result of our increased focus ... income for the three months to March 31, 2009 is lower than the same period in 2008 due to lower average ...

Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets

... and slower than originally projected and from a lower base of revenue. As a result, we are now ... $214.2 million in the fourth quarter of 2008. lower demand across most of the segment's service ... quarter operating margins were impacted by a lower level of study activity, costs related to the ...

ViroPharma Incorporated Reports First Quarter 2009 Financial Results

... write off arising from our book value being lower than our market capitalization at March 31, 2009, ... to the price increase in January 2009, offset by lower sales volumes. Cost of sales increased over ... write off arising from our book value being lower than our market capitalization at March 31, 2009, ...

Under the Microscope: 'Micro IVF'

... syndrome or producing financial hardship. Its lower cost and risk should outweigh diminished ... IVF, but because of the economy they opt for the lower price and subsequently, the lower chance of success. It worries me that in order to ...

Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009

... the same period. The Company attributes the lower third quarter sales growth rate to customer ... in the third quarter was primarily caused by lower gross margins in Europe resulting from ... prior-year periods, primarily as a result of lower rates of return on cash and available-for-sale ...

Flu vaccine given in microneedle skin patches proves effective in mice

... because of decreased pain, increased convenience, lower cost and simpler logistics over conventional ... convenient storage, easier transportation and lower dosage requirements. lower doses could be particularly important because flu ...

First Application to Fight High Cholesterol Launches on the iPhone and iPod Touch

... to track their cholesterol and, more importantly, lower their cholesterol by putting together an action ... to track their cholesterol and, more importantly, lower their cholesterol by putting together an action ... of the application is to motivate people to lower their cholesterol and keep it low. If the user ...

New Generation Biofuels Signs Sales Contract with Catoctin Mountain Growers to Supply up to 370,000 gallons of Renewable Biofuel

... Growers with our biofuel, which provides a lower carbon footprint and is 100 percent renewable," ... when replicated across the country, will help lower the net emission of greenhouse gases in the ... that its proprietary biofuel can provide a lower cost, renewable alternative energy source with ...

WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results

... of acquired intangible assets in 2008; and lower 2008 gross margins in our China-based ... 2008 and 44% in full-year 2008 were lower than 44% and 48%, respectively, for the ... financial results for AppTec, which had lower gross margins than our China-based ...

Publication of Shire plc's Annual Report 2008

... the following, which could result in lower prices for the Group's products and/or a reduced ... world market and imports that product from the lower price jurisdiction to the higher price jurisdiction. If the parallel importation of lower priced drugs is permitted in the US, it ...

ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results

... in interest income was primarily attributable to lower invested balances and interest rates. ... and other income was primarily attributable to lower interest income based on lower invested balances, offset by $0.1 million ...

Helix BioPharma Announces Q2 2009 Financial Results

... reflects higher purchase costs resulting from a lower Canadian dollar versus the U.S. dollar. ... the aforementioned increases in expenditures are lower wages and benefits due to a one-time charge ... ended January 31, 2008. Also contributing to the lower wages and benefits in the current quarter was the ...

AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results

... The decrease in revenues is primarily due to lower quarter-over-quarter royalties related to our ... still recognized as royalty revenues, has been lower than the royalty revenues recognized in the past, ... loss is largely attributable to a combination of lower sales and ...

Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results

... of 2007. This was due to the combination of a lower average cash balance on hand and lower interest rates during the most recent quarter. ... full-year 2007. This decrease was mainly due to lower interest rates and ...

Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008

... to achieve higher sales during 2008 on lower absolute levels of selling, general and ... has declined significantly, primarily due to lower than expected royalties derived from sales by our ... our business and cash position (including lower expected revenues derived from BSC), we did not ...

Vasogen Announces 2008 Year-End Results

... period in 2007. A key driver of this decrease was lower compensation costs, reduced stock compensation expense, lower infrastructure and other support costs driven by lower employee numbers in 2008, and a decrease in the ...

NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate Directed Against the Fusion (F) Protein

... which are important for preventing infection and lower respiratory illness, were highest in the "VLP ... RSV is the most commonly identified cause of lower respiratory tract infection in infants and young ... less than four years of age) may also develop lower respiratory tract infections leading to ...

INVO Bioscience Completes Reverse Merger

... "the company"), focused on creating simplified, lower cost treatment option for patients diagnosed with ... stimulation infertility treatment cycle, using lower amounts of injectable fertility hormones than ... Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed ...

Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008

... markets, France and Germany, partially offset by lower sales in the United Kingdom. Asia Pacific ... to a new distribution partner, resulted in lower year-over-year sales in that country. These ... sales and gross profit, as well as slightly lower R&D and SG&A expense, both of which ...
Other Contents
(Date:7/11/2014)... "mouse TRAP" to capture the early signs of kidney ... the Journal of Clinical Investigation . Their new ... extract cellular and genetic information from a variety of ... Institute for Medical Research in 2008, TRAP involves attaching ... of the cell type of interest. Scientists can then ...
(Date:7/11/2014)... from the Max Planck Institute for Medical Research in ... understanding photosynthesis, the process by which the Earth first ... and which is therefore crucial for all higher forms ... the first direct visualization of a crucial event in ... specific protein complex, photosystem II, splits water into hydrogen ...
(Date:7/11/2014)... division of the striatum is also involved in ... of substance P in the striatal marginal division ... his team, College of Biophotonics, South China Normal ... P receptor, neurokinin 1 was highly expressed in ... rats. Unilateral or bilateral injection of an antisense ...
Breaking Biology News(10 mins):A first direct glimpse of photosynthesis in action 2
(Date:7/13/2014)... BC (PRWEB) July 13, 2014 Victorian ... excitement by promoting the rental of bikes for its ... historic downtown Victorian Hotel to tour the area using ... plus tax. Bicycle enthusiasts love to call Vancouver home, ... options for cycle travel and picturesque journeys through the ...
(Date:7/13/2014)... 2014 The report “Micronutrient Market ... Form (Chelated & Non Chelated), Application Mode (Soil, ... Trends and Forecast to 2018” defines and segments ... and forecasting of the global value and volume ... and restraining factors for the global agriculture micronutrients ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 According ... Processing and Computing Market by Component (processor, GPU, ... Automotive, MDA, Medical), and Geography - Forecast and ... Heterogeneous Mobile Processing & Computing Market is expected ... a CAGR of 20.75% from 2014 to 2020. ...
(Date:7/13/2014)... Serena Gordon HealthDay Reporter ... type of sensor for people with diabetes is being developed ... of blood, researchers report. Scientists at Brown University in ... artificial saliva. It uses light, metal and a special enzyme ... knows that diabetics have to prick their fingers to draw ...
(Date:7/13/2014)... York, New York (PRWEB) July 13, 2014 ... lawsuits ( http://www.transvaginalmeshlawsuithelp.com/ ) filed against Johnson ... litigation’s second bellwether trial, which is expected to get ... Order issued in the U.S. District Court, Southern District ... Conference will be held on August 7, 2014 at ...
Breaking Medicine News(10 mins):Health News:Victorian Hotel Creates Excitement by Adding "Cycle the City" Bike Rentals for Its Vancouver Hotel Rooms 2Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 2Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 3Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 4Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 4
Other TagsOther Tags